Shining light on Hemolysis detection
Hear what your peers say
The GEM Premier 7000 with iQM3* is a breakthrough in blood gas testing—the only blood gas system capable of detecting hemolysis on whole blood samples at the point of care. News outlets are spotlighting its impact, as early adopters report improved patient management and decreased cost of care—making it a vital tool in today’s point-of-care testing environment.
.png?width=369&height=286&name=Group%20301%20(1).png)
Multi-Institution Comparison of Whole Blood Potassium Hemolysis Rates
A new publication published in Clinical Biochemistry, reports an overall hemolysis rate of 10% across departments including the emergency department (ED), intensive care unit (ICU), neonatal ICU (NICU), and other inpatient units in four institutions. Samples collected in the ED showed even higher rates, with levels reported as high as 17%.1
"This study demonstrates the importance of hemolysis detection in whole blood specimens and at the POC for improving laboratory quality and patient safety."1
READ THE PAPER IN CLINICAL BIOCHEMISTRY
Handling Hemolytic Blood Samples from High-Risk Clinical Areas
Published in The Journal of Applied Laboratory Medicine, this special report discusses the importance of in vitro hemolysis as a significant preanalytical error with potential for serious consequences in acute care settings.2 It highlights variability in current practices and emphasizes the need for hemolysis detection in whole blood and provides six recommendations as a call to action to address this significant preanalytical error.
READ THE PAPER IN THE JOURNAL OF APPLIED LABORATORY MEDICINE
The Ohio State University Experience in the ED
The Ohio State University in Columbus, OH was featured on TV news station, NBC4 Raleigh, highlighting how point-of-care hemolysis detection enhances treatment speed and accuracy, while reducing healthcare costs.3
“I’m very lucky to work at Ohio State, one of the first places in the country to use this type of blood gas analyzer.”3
– Robert Cooper, MD, Clinical Associate Professor of Emergency Medicine, Ohio State University
HEAR WHAT THE OHIO STATE UNIVERSITY CLINICIANS HAVE TO SAY
University of Kentucky HealthCare Experience in Neonatal Care
UK HealthCare in Lexington, KY was featured in a story on TV news station Spectrum 1, showcasing how hemolysis detection in the NICU enhances diagnostic accuracy, reduces treatment delays, and minimizes the need for repeat samples on a vulnerable patient population.4
"When you’re dealing with premature infants or just babies in general, you are limited to how much blood you can draw. You might need to make clinical decisions and treatment decisions based on that result. If you don’t know that it’s (hemolysis) there, that could go missed and negatively impact the patient.”4
- Robert Maynard, PhD, Assistant Professor of Pathology and Laboratory Medicine, UK College of Medicine
HEAR WHAT UK HEALTHCARE CLINICANS HAVE TO SAY
New system for hemolysis detection at point of care
Featured in the October 2024 issue of CAP Today, the GEM Premier 7000 with iQM3 is the first blood gas system to detect hemolysis at the point of care.5
“[Hemolysis is] like the elephant in the room. While it's obvious to laboratorians, it is not openly discussed because that would highlight a deficiency.”5
– Alan Wu, PhD, Professor of Laboratory Medicine, University of California San Francisco
READ THE CAP TODAY ARTICLETestimonials
Chris W. Farnsworth, PhD
Associate Professor, Pathology and Immunology
Washington University School of Medicine
Medical Director, Clinical Chemistry, and Point-of-Care Testing
Barnes Jewish Hospital
St Louis, MO
One game-changing breakthrough in 2024 was the emergence of hemolysis detection in whole blood for blood gas testing with the GEM Premier 7000.
Heather Stieglitz, PhD
Clinical Assistant Professor, Department of Pathology
The
Ohio State University College of Medicine
Co-Director, Clinical Chemistry and Toxicology
The Ohio State University, Wexner Medical Center
Columbus, OH
Hemolysis is an important preanalytical variable that definitely occurs in blood gas samples at the point of care, and we were not able to detect it before. Werfen’s is the first testing system that allows us to measure for that potential preanalytical variable in these samples.
